Wth a Series B €40m financing, Novadip Biosciences SA has raised investements to a total of €88m. It will use the proceeds to push two single-use cell therapies designed to accelerate healing.
Three small-scale studies hinted at new COVID-19 vaccination boosters not significantly enhancing the immune response to Omicron variant.
Antibody developer Memo Therapeutics AG has snaged a R&D partnership with Ono Pharmaceutical Co. Ltd in the immuno-oncology field.
Catalonia’s healthcare start-ups raised €238m in 2021, a new record and 4% up from 2020. Four fifth (83%) of VC came from international investors.
The European Council has adopted three regulations aimed at improving pandemic preparedness, which together with two other pillars complete the EU Health Union.
Automotive company Audi AG and gas fermentation specialist Krajete GmbH are building a highly effective industrial-scale CO2 Direct Air Capturing plant in Linz.
Finnish Solar Foods Ltd has got the first ever novel food authorisation for its microbially-produced protein powder Solein.
Bone Therapeutics has merged with French inflammatory/autoimmune company Medsenic in a €40m deal and changed its name into BioSenic.
Cambridge-based Enhanc3D Genomics Ltd has raised £10m in Series A financing led by BGF and Parkwalk Advisors.